COVID-19 Disruption: Challenges for Life Sciences Companies (and Beyond); Cash flow strategies are paramount, then come "postscript" considerations

Saved in:
Bibliographic Details
Published in:The Tax executive 2020-07, Vol.72 (4), p.36
Main Authors: Majure, Kim, Atkinson, James, Abaci, Luis, Cody, Brian, De Jong, Dan, Bloom, Brett
Format: Article
Language:English
Subjects:
Biotechnology industries
Biotechnology industry
Cash flow
Corporate income taxes
COVID-19
Economic aspects
Finance
Laws, regulations and rules
Management
Taxation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0040-0025